Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.185 EUR | +20.13% | +40.15% | -11.90% |
2023 | Octopus Biosafety SA Auditor Raises 'Going Concern' Doubt | CI |
2023 | Octopus Biosafety SA Reports Earnings Results for the Full Year Ended December 31, 2022 | CI |
Business Summary
This solution makes it possible to fight effectively against multi-resistant bacteria, pandemics and bioterrorism. Moreover, multiple on-board sensors ensure a full data traceability.
Sales per Business
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Services
55.6
%
| 0 | 9.4 % | 0 | 55.6 % | +93.89% |
Robot Merchandise
27.1
%
| - | - | 0 | 27.1 % | - |
Robot Production
17.4
%
| 0 | 90.6 % | 0 | 17.4 % | -93.75% |
Sales per region
EUR in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
France
100.0
%
| 1 | 100.0 % | 0 | 100.0 % | -96.23% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Bertrand Vergne
CEO | Chief Executive Officer | - | 19-12-31 |
Élodie Giroux
COO | Chief Operating Officer | - | 20-06-30 |
Dorian Pierre
CTO | Chief Tech/Sci/R&D Officer | - | 20-12-31 |
Sales & Marketing | - | 21-05-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Bertrand Vergne
CEO | Chief Executive Officer | - | 19-12-31 |
Director/Board Member | 74 | 20-10-21 | |
Director/Board Member | 49 | 21-06-28 | |
Director/Board Member | 43 | 21-06-28 |
Company contact information
Sector
Sales per Business
- Stock Market
- Equities
- MLOCT Stock
- Company Octopus Biosafety